biological research safetybiological safety cabinetsbiological research approvalinter-institutional biological and recombinant dna committee (ibrdsc)bloodborne pathogensuniversal precautionsshipping biological materialsselect agentspolicies and guidelinesreference materialsbiological safety formssafety sites and organizationspractical bsl-2 training |
Shipping Biological Materials
The U.S. Department of Transportation (US DOT) and the International Air Transport
Association (IATA) requires you be trained and certified before shipping biological
and bio-hazardous materials. Even if someone else handles your shipment for you, you
are responsible for packaging and labeling biological materials correctly, and providing
the required documentation. Fines for non-compliance and potential legal action can
occur if you are found to have willfully ignored hazardous materials shipping regulations.
Materials Regulated by DOT/IATA
The following materials are regulated by DOT/IATA and require special packaging, labeling,
and documentation.
In addition, you must complete a Material Transfer Agreement (MTA) to ship materials off campus, and ensure any required permits to import, export,
or transfer materials have been obtained.
Category A Infectious Substances
- An infectious substance which is transported in a form that, when exposure to the
material occurs, is capable of causing permanent disability, life-threatening or fatal
disease in otherwise health humans or animals.
- A diagnostic specimen that is suspected of containing a Category A Infectious Substance.
- A patient specimen that is suspected of containing a Category A Infectious Substance.
Category A Substances Affecting Humans
- Bacillus anthracis (cultures only)
- Brucella abortus (cultures only)
- Brucella melitensis (cultures only)
- Brucella suis (cultures only)
- Burkholderia mallei - Pseudomonas mallei - Glanders (cultures only)
- Burkholderia pseudomalli -Pseudomonas pseudomallei (cultures only)
- Chlamydia psittaci - avian strains (cultures only)
- Clostridium botulinum (cultures only)
- Coccidioides immitis (cultures only)
- Coxiella burnetii (cultures only)
- Crimean-Congo hemorrhagic fever virus
- Dengue virus (cultures only)
- Eastern equine encephalitis virus (cultures only)
- Escherichia coli, verotoxigenic (cultures only)
- Ebola virus
- Flexal virus
- Francisella tularensis (cultures only)
- Guanarito virus
- Hantaan virus
- Hantaviruses causing hantavirus pulmonary syndrome
- Hendra virus
- Hepatitis B virus (cultures only)
- Herpes B virus (cultures only)
- Human immunodeficiency virus (cultures only)
- Highly pathogenic avian influenza virus (cultures only)
- Japanese Encephalitis virus (cultures only)
- Junin virus
- Kyasanur Forest disease virus
- Lassa virus
- Machupo virus
- Marburg virus
- Monkeypox virus
- Mycobacterium tuberculosis (cultures only)
- Nipah virus
- Omsk hemorrhagic fever virus
- Poliovirus (cultures only)
- Rabies virus
- Rickettsia prowazekii (cultures only)
- Rickettsia rickettsii (cultures only)
- Rift Valley fever virus
- Russian spring-summer encephalitis virus (cultures only)
- Sabia virus
- Shigella dyseteriae type 1 (cultures only)
- Tick-borne encephalitis virus (cultures only)
- Variola virus
- Venezuelan equine encephalitis virus
- West Nile virus (cultures only)
- Yellow fever virus (cultures only)
Category A Substances Affecting Humans
- African swine fever virus cultures
- Avian paramyxovirus type 1—Velogenic Newcastle disease virus cultures
- Classical swine fever virus cultures
- Foot and mouth disease virus cultures
- Lumpy skin disease virus cultures
- Mycoplasma mycoides—Contagious bovine pleuropneumonia cultures
- Peste des petits ruminants virus cultures
- Rinderpest virus cultures
- Sheep-pox virus cultures
- Goatpox virus cultures
- Swine vesicular disease virus cultures
Category B Infectious Substances
- Category B infectious substances are those infectious substances which do not meet
the criteria for inclusion in Category A.
- A diagnostic specimen that is suspected of containing Category B Infectious substances.
- A patient specimen that is suspected of containing Category B Infectious substances.
Genetically Modified Organisms
- Organisms and micro-organisms in which genetic material has been purposefully altered
through genetic engineering in a way that does not occur naturally and which are capable
of altering animals, plants, or microbiological substances in such a way which is
not normally the result of natural replication or reproduction.
Dry Ice
- The shipment of ANY biological materials on dry ice is regulated
- It is illegal to ship regulated biological material without proper training due to
the ever-changing regulations and heavy documentation that must accompany each shipment.
Training is also required when dry ice is used as refrigerant.
Materials Not Regulated by DOT/IATA
The following are not regulated for shipping by IATA/DOT unless they are packaged
with another material that is regulated (e.g. dry ice); however, you must still complete
a Material Transfer Agreement (MTA) to ship materials off campus.
Materials Exempt from IATA/DOT Regulations
- Patient specimens with minimal likelihood that pathogens are present.
- Patient specimens are defined as those collected directly from humans or animals,
including, but not limited to: excreta, secreta, blood and its components, tissue
and tissue fluid swabs, and body parts being transported for purposes such as research,
diagnosis, investigational activities, disease treatment and prevention.
- In determining whether a patient specimen has a minimal likelihood that pathogens
are present, an element of professional judgment is required to determine if a substance
is exempt. That judgment should be based on the known medical history, symptoms and
individual circumstances of the source, human or animal, and endemic local conditions.
- Examples of specimens that can be transported as patient specimens:
- Blood or urine tests to monitor cholesterol levels, blood glucose levels, hormone
levels, or prostate specific antigens.
- Tests required to monitor organ function such as heart, liver or kidney function for
humans or animals with non-infectious diseases, or therapeutic drug monitoring.
- Tests conducted for insurance or employment purposes and are intended to determine
the presence of drugs or alcohol
- Pregnancy tests
- Biopsies to detect cancer
- Antibody detection
- NOTE - Patient specimen packaging must be labeled either "Exempt human specimens"
or "Exempt animal specimens".
- Substances that do not contain infectious substances or substances which are unlikely
to cause disease in humans and/or animals.
- Substances in a form that any present pathogens have been neutralized or inactivated
such that they no longer pose a health risk.
- Substances containing microorganisms, which are non-pathogenic to humans and/or animals.
- Dried blood spots collected by applying a drop of blood onto absorbent material, or
fecal occult blood screening tests and blood or blood components, which have been
collected for transfusion.
- Tissue or organs intended for transplantation.
- Environmental samples (including food, water, and soil samples), which are not considered
to pose a significant risk of infection.
Additional Information
For assistance in shipping biological materials, please contact Dr. Sarah Keeton at
sorlik1@lsu.edu. Training may be required and can be found online in EHS-Assistant.
|